Foot and Ankle / Osteoarthritis / Shockwave / VAS+FFI

This Circle helps physicians capture and monetize real-world data from their everyday delivery of Shockwave for Foot Osteoarthritis.

The Shockwave Market was valued at $1.34 Billion in 2023, and is estimated to grow to $2.4 Billion by 2030. The prevalence of Foot Osteoarthritis is approximately 20-30% of people aged 50 and older. With global life expectancy increasing, manufacturers will increase spending to obtain regulatory approvals for marketing shockwave products. Increasingly, that spend will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Foot Osteoarthritis cases, outcomes and other case data.